以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
GH
13 atoms · 跨 2 天 · 首见 2026-05-15 · 最近 2026-06-05
三色: 🟦 fact 5 · 🟥 take 8 · stance ▲6/▼1/◆0
来源: X 13
时态: fresh:11 · stale:2
标签: 好观点:8 · 好数字:7 · 好信源:5
叙事 (narrative) (3)
- 2026-06-05 · 近期增长驱动因素
Guardant has several near-term growth drivers, including 1) the recent FDA approval of its G360 CDx 740-gene panel, 2) the continued volume ramp of tissue-based therapy selection and CRC screening, and 3) the upcoming launch of its tumor-informed MRD test
tags: 好观点 · → daily
value: qty=FDA approval of G360 CDx 740-gene panel, volume ramp, MRD launch
- 2026-05-15 · 烧钱量
烧钱最多
tags: 好观点 · → daily
- 2026-05-15 · 2026年走势特征
低位震荡、弹性大
tags: 好观点 · → daily
预测 (forecast) (2)
- 2026-06-05 · FCF 盈亏平衡时间
on track to achieve free cash flow breakeven in 2027
tags: 好数字·好观点 · → daily
value: date=2027
- 2026-06-05 · 新 FDA 批准预期影响
we believe this approval could spur both commercial advantages in the market and more favorable reimbursement dynamics over time
tags: 好观点 · → daily
value: qty=commercial advantages, more favorable reimbursement
立场 (position) (2)
展开 2 条老旧 / 已过期
- 2026-06-05
[老旧] · GS 评级
Goldman Sachs Initiates Coverage on $GH with Buy Rating
tags: 好观点 · → daily
value: qty=Buy
- 2026-06-05
[老旧] · GS 目标价
PT $165
tags: 好数字·好观点 · → daily
value: qty=$165 · date=12-month
事实 (fact) (6)
- 2026-06-05 · Guardant360 CDx 首次 FDA 批准时间
GH originally received pan-cancer FDA approval for Guardant360 CDx in August 2020
tags: 好数字·好信源 · → daily
value: date=August 2020
- 2026-06-05 · Guardant360 初始基因覆盖数
This FDA-approved test covered ~74 genes
tags: 好数字·好信源 · → daily
value: qty=~74 genes
- 2026-06-05 · Smart Liquid Biopsy 平台升级时间
the company upgraded an LDT version of the Guardant360 test to its Smart Liquid Biopsy platform in 2024
tags: 好数字·好信源 · → daily
value: date=2024
- 2026-06-05 · Smart Liquid Biopsy 基因覆盖数
which included 740 genes
tags: 好数字·好信源 · → daily
value: qty=740 genes
- 2026-06-05 · G360 CDx 740-gene 版本 FDA 批准时间
This more comprehensive version of the test also received FDA approval in May 2026
tags: 好数字·好信源 · → daily
value: date=May 2026
- 2026-06-05 · 市场地位
the Guardant360 test...continues to hold the market-leading position
tags: 好观点 · → daily
value: qty=market-leading
时间轴 (近 20)
- 2026-06-05 ·
position · GS 评级 · → daily
- 2026-06-05 ·
position · GS 目标价 · → daily
- 2026-06-05 ·
narrative · 近期增长驱动因素 · → daily
- 2026-06-05 ·
forecast · FCF 盈亏平衡时间 · → daily
- 2026-06-05 ·
fact · 市场地位 · → daily
- 2026-06-05 ·
fact · Guardant360 CDx 首次 FDA 批准时间 · → daily
- 2026-06-05 ·
fact · Guardant360 初始基因覆盖数 · → daily
- 2026-06-05 ·
fact · Smart Liquid Biopsy 平台升级时间 · → daily
- 2026-06-05 ·
fact · Smart Liquid Biopsy 基因覆盖数 · → daily
- 2026-06-05 ·
fact · G360 CDx 740-gene 版本 FDA 批准时间 · → daily
- 2026-06-05 ·
forecast · 新 FDA 批准预期影响 · → daily
- 2026-05-15 ·
narrative · 烧钱量 · → daily
- 2026-05-15 ·
narrative · 2026年走势特征 · → daily
← 实体目录 · 系统日志